← Leaderboards
Elisa De Stanchina
Sloan-Kettering Inst Can Research
$4,011,743
Attributed
$4,011,743
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $848.8K · FY2014–25$1M$750K$500K$250K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,011,743 · 4
By mechanism
P30$3,173,933 · 2
P50$837,810 · 2
Top collaborators
No co-investigators on record.
Most similar at Sloan-Kettering Inst Can Research
Same institution · by research overlap
- Neil Scott Lipman$40,385,405
- David B. Solit$21,393,031
- Nicholas D Socci$8,843,502
- Li-Xuan Qin$4,528,993
- Alexander Drilon$4,847,187
Others in their field
Top investigators on “Translational Research”
- Leonard Freedman · Leidos Biomedical Research, Inc.$362,430,297
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$293,499,096
- Steven E Reis · University Of Pittsburgh At Pittsburgh$280,623,952
- David Heimbrook · Leidos Biomedical Research, Inc.$270,029,156
- Gregory H Reaman · National Childhood Cancer Foundation$259,780,965
- Lee Marshall Nadler · Dana-Farber Cancer Inst$240,966,783
Research focus
Translational ResearchResearch PersonnelServicesDesignAnimalsResourcesToxic EffectIn VivoProtocols DocumentationEfficacy StudyMissionRouteCore FacilityTechnical ExpertiseTissue ProcurementsPreclinical StudyApplications GrantsOrganic SynthesisCancer Center Support GrantDrug KineticsCytologyEvaluationAdvisory ServicesMouse Model
Grant awards (21)
Antitumor Assessment$613,728
P30 · FY2025 · CA · contact PI
Core 2: Biospecimen$235,097
P50 · FY2025 · CA · contact PI
Antitumor Assessment$226,009
P30 · FY2024 · CA · contact PI
Core 2: Biospecimen$165,975
P50 · FY2024 · CA · contact PI
Antitumor Assessment$230,112
P30 · FY2023 · CA · contact PI
Core 2: Biospecimen$102,437
P50 · FY2023 · CA · contact PI
Antitumor Assessment$230,112
P30 · FY2022 · CA · contact PI
Core 2: Biospecimen$158,922
P50 · FY2022 · CA · contact PI
Antitumor Assessment$230,112
P30 · FY2021 · CA · contact PI
Core 2: Biospecimen$175,379
P50 · FY2021 · CA · contact PI
Antitumor Assessment$230,112
P30 · FY2020 · CA · contact PI
Antitumor Assessment$229,586
P30 · FY2019 · CA · contact PI
Antitumor$222,124
P30 · FY2018 · CA · contact PI
Antitumor$21,115
P30 · FY2018 · CA · contact PI
Antitumor$13,274
P30 · FY2018 · CA · contact PI
Antitumor$4,924
P30 · FY2018 · CA · contact PI
Antitumor$2,734
P30 · FY2018 · CA · contact PI
Antitumor$253,618
P30 · FY2017 · CA · contact PI
Antitumor$222,125
P30 · FY2016 · CA · contact PI
Antitumor$222,123
P30 · FY2015 · CA · contact PI
Antitumor$222,125
P30 · FY2014 · CA · contact PI